Whether her department is funding any programmes on the development of medicines for treating tuberculosis and multi drug resistant tuberculosis; if not, why not; if so, (a) through which entity, (b) where are the programmes being carried out, (c) what is the cost of each programme and (d) what are the relevant details of the (i) progress that has been made in terms of and (ii) success rate for each specified programme?